HIV Vaccine
Preclinical development program initiated for new HIV vaccine candidate
Published in AIDS Weekly, December 1st, 2003
The program is based on the promising results obtained from proof-of-concept studies with IR103, and is designed to provide data that would support regulatory filings for phase I clinical studies.
IR103 combines Amplivax, an adjuvant being developed by Hybridon, Inc. (HYBN), to enhance the immune response to a vaccine antigen, with the HIV-1 Immunogen technology employed in Remune, an immune-based therapeutic vaccine currently being evaluated in phase II...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2003-12-01)
More Articles from AIDS Weekly
- HIV/AIDS Immunotherapy
IL-7 safely stimulates T-cell renewal in SIV-infected macaques - HIV/AIDS Risk Factor
Alpha1-antitrypsin gene mutations may raise HIV infection risk - HIV/AIDS Diagnostics
Heat-denatured signal-amplified HIV p24 assay suitable for use in developing areas - HIV/AIDS Diagnostics
Novel molecular HIV test has single-copy sensitivity for viral RNA - HIV/AIDS Lipodystrophy
Elevated cytokine levels in adipose tissue suppress adiponectin output in HALS patients - HIV/AIDS Therapy
Long-term HAART does not lead to full T-cell recovery - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
